Copertina

Ezh2 Inhibits the Differentiation of Short‐Lived Effector CD8 + T Cells and Promotes T Cell‐Dependent Antitumor Immunity

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Kenji Takagi, Junpei Suzuki, Yuko Matsuoka, Makoto Kuwahara, Taro Oshikiri, Masakatsu Yamashita
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Cancer Science
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

KLHL5 Contributes to Colorectal Cancer Cell Survival by Promoting Cell Cycle Progression and Suppressing Apoptotic Cell Death
di: Kyosuke Habu, et al.
Pubblicazione: (2025)

BCL‐2 Inhibitor Regulates Number, Function, and Antitumor Immunity of T Cells by Influencing Glycolysis in AML
di: Xiaohuan Peng, et al.
Pubblicazione: (2025)

PC4 Potentially Predicts Chemoradiation‐Induced Antitumor Immunity in Esophageal Squamous Cell Carcinoma
di: Jieyong Tian, et al.
Pubblicazione: (2025)

From Genomic and Epigenomic Maps to Medicines in Adult T‐Cell Leukemia/Lymphoma
di: Kako Suzuki, et al.
Pubblicazione: (2025)

ACT001 Suppresses the Malignant Progression of Small‐Cell Lung Cancer by Inhibiting Lactate Production and Promoting Anti‐Tumor Immunity
di: Xiao‐Jing Ding, et al.
Pubblicazione: (2025)

Dual Role of LBH589 in Triple‐Negative Breast Cancer: Inhibition of Tumor Growth and Enhancement of Antitumor Immunity
di: Liang Anjing, et al.
Pubblicazione: (2026)

Combination of LowDose Epigenetic Modifiers and TIC10 for the Activation of Antitumor Immunity and Inhibition of Tumor Growth in Gastrointestinal Cancer
di: Jianling Zou, et al.
Pubblicazione: (2025)

Correction to “ CD4 + T Cells Mediate Dendritic Cell Licensing to Promote Multi‐Antigen Anti‐Leukemic Immune Response”
Pubblicazione: (2025)

Lymph Node Invasion by Melanoma Cells Is Not Required for the Induction of Incomplete Differentiation by Tumor‐Specific CD8+ T Cells
di: Kristian M. Hargadon, et al.
Pubblicazione: (2025)

Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors
di: Aaron B. Ross, et al.
Pubblicazione: (2025)

Recurrent Immune‐Effector Cell‐Associated Neurotoxicity Syndrome With Atypical Manifestations after Tisagenlecleucel
di: Devin Murphy, et al.
Pubblicazione: (2025)

Activation of cGAS ‐ STING Pathway by DAI ‐Triggered Ferroptosis in CRC Cells Reprograms TAMs Balance to Promote Anti‐Tumor Immunity
di: Pengrui Cheng, et al.
Pubblicazione: (2025)

Pseudonormal Morphology of Salivary Gland Adenoid Cystic Carcinoma Cells Subverts the Antitumor Reactivity of Immune Cells: A Tumour‐Cell–Based Initiation of Immune Evasion
di: Rajdeep Chakraborty, et al.
Pubblicazione: (2024)

Differentiation of Cytotoxic CD8+ T Cell Subsets Under Tumor Progression: Can CD69 Be a New Therapeutic Target?
di: Ryo Koyama‐Nasu, et al.
Pubblicazione: (2025)

Hepatic‐Differentiated Subpopulation in Clear Cell Renal Cell Carcinoma: A Multi‐Omics Analysis of Tumors With Lymphovascular Invasion
di: Shugo Yajima, et al.
Pubblicazione: (2026)

RNF135 Promotes Human Osteosarcoma Cell Growth and Inhibits Apoptosis by Upregulating the PI3K/AKT Pathway
di: Bingyao Chen, et al.
Pubblicazione: (2024)

Ligand‐Based CAR‐T Cells Targeting EGFR Exhibit Favorable Antitumor Effects Against Gynecologic Malignancies
di: Manaka Shinagawa, et al.
Pubblicazione: (2025)

Cell Biology of Cancer Peritoneal Metastasis: Multiclonal Seeding and Peritoneal Tumor Microenvironment
di: Hideki Yamaguchi, et al.
Pubblicazione: (2025)

The LGALS9 / miR ‐491‐5p Axis Regulates CD8 + T Cell Function and Inhibits the Progression of Gastric Cancer
di: Wanzhong Huang, et al.
Pubblicazione: (2025)

Translational Inhibition of Slug by Pdcd4 Contributes to Invasion Inhibition in Colorectal Cancer Cells
di: Qing Wang, et al.
Pubblicazione: (2025)

Cyclosporine Resolved Late Graft Failure After Autologous Transplantation for Neuroblastoma by Promoting CD4 T‐Cell Recovery
di: Yu Shiguta, et al.
Pubblicazione: (2026)

UBE 2 C ‐Mediated CD 147‐ CTLA ‐4 Axis Promotes T Cell Exhaustion and Immunosuppressive Microenvironment in Bladder Cancer
di: Xuwei Hong, et al.
Pubblicazione: (2026)

Natural Product 4‐Acetylantroquinonol B Enhances NK Cell‐Mediated Immunity Against Glioblastoma
di: Yuan‐Chieh Yeh, et al.
Pubblicazione: (2026)

circ‐TTC17 Promotes Esophagus Squamous Cell Carcinoma Cell Growth, Metastasis, and Inhibits Autophagy‐Mediated Radiosensitivity Through miR‐145‐5p/SIRT1 Axis
di: Ying Liu, et al.
Pubblicazione: (2024)

The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B‐Cell Lymphoma
di: Zhenhan Zhu, et al.
Pubblicazione: (2024)

Aberrant Hematopoiesis and CD8+ T‐Cell Activation in Thymoma‐Associated Pure Red Cell Aplasia
di: Mengyuan Liu, et al.
Pubblicazione: (2025)

Cancer‐Type‐Specific DNA Methylation Is a Source of Vulnerability in Liver Cancer Cells
di: Karen Minowa, et al.
Pubblicazione: (2025)

Effect of Fluence Rate on Tumor Tissue Damage in IRDye700DX‐Based Photoimmunotherapy
di: Susumu Yamashita, et al.
Pubblicazione: (2025)

Synergistic Antitumor Efficacy of Radiofrequency Ablation Combined With TROP2 ‐ CAR ‐T Cells in a Xenograft Mouse Model of Lung Adenocarcinoma
di: Yanyun Zhao, et al.
Pubblicazione: (2026)

Connexin43 Promotes the Invasion and Metastasis of Lung Squamous Cell Carcinoma via GJIC‐Dependent Ca2+/ERK Signaling Activation
di: Xiaocheng Mo, et al.
Pubblicazione: (2025)

Transcutaneous Imiquimod Combined With Anti‐Programmed Cell Death‐1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma
di: Takashi Karashima, et al.
Pubblicazione: (2025)

Docetaxel‐Induced Immune Activation Shows Antitumor Synergy With the Tumor‐Targeted CD40 Agonist KK2269
di: Yuta Tezuka, et al.
Pubblicazione: (2026)

T‐Cell Immunoglobulin and Mucin Domain 1 (Tim1) as a Prognostic Factor Associated With Therapeutic Resistance in Human Breast Carcinoma
di: Mio Yamaguchi-Tanaka, et al.
Pubblicazione: (2026)

Ligand‐Receptor Interactions Between Squamous and Endothelial Cells Induce Head and Neck Squamous Cell Carcinoma
di: Takahiro Ishiyama, et al.
Pubblicazione: (2025)

NFAT5 Regulates IL8 to Promote Cell Growth and Migration in Non‐Small Cell Lung Cancer
di: Jinliang Chen, et al.
Pubblicazione: (2025)

Dexamethasone Inhibits the Growth of B‐Lymphoma Cells by Downregulating DOT1L
di: Yuting Wang, et al.
Pubblicazione: (2024)

SLPI / FBW7 /c‐Myc Axis Reduces Gemcitabine Sensitivity in PDAC by Enhancing Glycolysis and Impairing NK Cell Immunity
di: Haofei Chen, et al.
Pubblicazione: (2026)

Combined Inhibition of ATR and Ribonucleotide Reductase Induces Synergistic Antineoplastic Activity in Osteosarcoma Cells
di: Natalie Aderhold, et al.
Pubblicazione: (2026)

Inhibition of Growth and Induction of Apoptosis of Human Prostate Cancer Cells by Enzymatic Blockage of Kallikreins
di: Fabienne Lehner, et al.
Pubblicazione: (2026)

KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma
di: Yoshinori Nakano, et al.
Pubblicazione: (2026)